Intravenous Iron Administration and Hypophosphatemia in Clinical Practice

Table 2

Comparison between patients developing hypophosphatemia after FCM injection and patients without hypophosphatemia.

	Patients with hypophosphatemia	Patients without hypophosphatemia
	38	40
Women/men	27/11	27/13	NS
Age	57 ± 11	58 ± 19	NS
Vitamin D level before injection (ng/mL)	21.9 ± 16.9	20 ± 10	NS
Hemoglobin (g/L)	9.5 ± 1.3	9.7 ± 1.8	NS
Ferritin (µg/L)	44 (6.25–55)	80 (9–95)
Cumulated dose (mg)	2092 ± 2002	1350 ± 860